TNGX
Tango Therapeutics Inc
NASDAQ · Biotechnology
$12.51
+0.56 (+4.69%)
Open$12.47
Previous Close$11.95
Day High$13.18
Day Low$12.30
52W High$13.46
52W Low$1.03
Volume—
Avg Volume2.30M
Market Cap1.68B
P/E Ratio—
EPS$-0.92
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+125.7% upside
Current
$12.51
$12.51
Target
$28.24
$28.24
$22.54
$28.24 avg
$42.65
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 51.88M | 49.72M | 413.09M |
| Net Income | -160,656,301 | -138,576,452 | -93,643,538 |
| Profit Margin | -309.7% | -294.2% | -22.7% |
| EBITDA | -167,053,462 | -152,099,663 | -104,097,067 |
| Free Cash Flow | — | — | -55,440,037 |
| Rev Growth | +4.3% | +4.3% | +5.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |